These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 31625159

  • 1. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, Chebib M, McGregor IS, Arnold JC.
    Epilepsia; 2019 Nov; 60(11):2224-2234. PubMed ID: 31625159
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN, Szaflarski JP, Gidal B, VanLandingham K, Critchley D, Morrison G.
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cannabidiol efficacy and clobazam status: A systematic review and meta-analysis.
    Lattanzi S, Trinka E, Striano P, Zaccara G, Del Giovane C, Nardone R, Silvestrini M, Brigo F.
    Epilepsia; 2020 Jun; 61(6):1090-1098. PubMed ID: 32452532
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interactions between cannabidiol and Δ9 -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome.
    Anderson LL, Low IK, McGregor IS, Arnold JC.
    Br J Pharmacol; 2020 Sep; 177(18):4261-4274. PubMed ID: 32608111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS.
    Epilepsy Curr; 2019 Sep; 19(2):93-95. PubMed ID: 30955420
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic synergism contributes to the antiseizure action of cannabidiol and clobazam.
    Rana RR, Rajasekaran K, Knappertz V, Gray RA.
    Exp Neurol; 2023 Feb; 360():114286. PubMed ID: 36442674
    [Abstract] [Full Text] [Related]

  • 18. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S, Trinka E, Striano P, Rocchi C, Salvemini S, Silvestrini M, Brigo F.
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis.
    Talwar A, Estes E, Aparasu R, Reddy DS.
    Exp Neurol; 2023 Jan; 359():114238. PubMed ID: 36206805
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.
    Jullien V, Chhun S, Rey E, Dulac O, Tod M, Chiron C, Pons G.
    Clin Pharmacokinet; 2015 May; 54(5):527-36. PubMed ID: 25503589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.